ClouDr Group Limited
HKSE 9955.HK
ClouDr Group Limited Price to Earnings Ratio (P/E) on January 14, 2025: -1.97
-
ClouDr Group Limited 52-week high Price to Earnings Ratio (P/E) is -1.74 on September 11, 2024, which is 11.48% above the current Price to Earnings Ratio (P/E).
-
ClouDr Group Limited 52-week low Price to Earnings Ratio (P/E) is -9.48 on January 15, 2024, which is -380.99% below the current Price to Earnings Ratio (P/E).
-
ClouDr Group Limited average Price to Earnings Ratio (P/E) for the last 52 weeks is -3.94.
| Date | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) | Dividend Yield |
|---|
| CEO | Ms. Lili Xu CPA |
| IPO Date | July 6, 2022 |
| Location | China |
| Headquarters | Rooms 401, 403 and 405(A) |
| Employees | 1,558 |
| Sector | Health Care |
| Industries | |
ClouDr Group Limited, an investment holding company, provides supplies and software as a service (SaaS) to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for chronic condition management. It distributes hospital supplies, which include medical devices, such as blood glucose meters and vital sign monitors, glucose testing strips, and OTC and prescription drugs; and hospital and pharmacy SaaS and digital marketing services to pharmaceutical companies. The company also provides real time consultation, digital condition tracking, and online prescription and ordering services. ClouDr Group Limited was founded in 2014 and is headquartered in Hangzhou, China.
Past 5 years
USD 1.93
StockViz Staff
January 15, 2025
Any question? Send us an email